# Bolt Biotherapeutics (BOLT) — Earnings

BOLT · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/bolt/earnings

## Most recent quarter

| Metric | Value |
| --- | --- |
| Fiscal period | Q2 2025 |
| Period end | Jun 30, 2025 |
| EPS actual | −$4.46 |
| EPS estimate | −$6.30 |
| EPS surprise | +29.21% |
| Revenue surprise | +119.58% |
| Revenue | $1.8M |
| Revenue estimate | $819,750.00 |
| Reported | Aug 14, 2025 |
| SEC filing | [View filing](https://www.sec.gov:443/Archives/edgar/data/1641281/000164128125000007/bolt-20250630.htm) |

## Earnings history

| Fiscal period | Report date | EPS estimate | EPS actual | Surprise | Revenue estimate | Revenue actual |
| --- | --- | --- | --- | --- | --- | --- |
| Q2 2025 | Aug 14, 2025 | −$6.30 | −$4.46 | 29.21% | $819,750.00 | $1.8M |
| Q1 2025 | May 12, 2025 | −$7.10 | −$5.80 | 18.31% | $757,250.00 | $1.2M |
| Q4 2024 | Mar 24, 2025 | −$7.60 | −$8.40 | -10.53% | $775,667.00 | $10,000.00 |
| Q3 2024 | Nov 12, 2024 | −$6.80 | −$8.00 | -17.65% | $1.3M | $1.1M |
| Q2 2024 | Aug 13, 2024 | −$8.76 | −$11.20 | -27.85% | $1.0M | $1.3M |
| Q1 2024 | May 14, 2024 | −$10.20 | −$5.60 | 45.10% | $2.1M | $5.3M |
| Q4 2023 | Mar 21, 2024 | −$9.40 | −$9.40 | 0.00% | $1.7M | $2.1M |
| Q3 2023 | Nov 9, 2023 | −$10.00 | −$8.60 | 14.00% | $1.7M | $2.5M |
| Q2 2023 | Aug 7, 2023 | −$9.53 | −$9.60 | -0.70% | $1.9M | $1.4M |
| Q1 2023 | May 11, 2023 | −$10.00 | −$9.00 | 10.00% | $1.5M | $1.8M |
| Q4 2022 | Mar 29, 2023 | −$11.73 | −$10.60 | 9.66% | $1.2M | $1.4M |
| Q3 2022 | Nov 10, 2022 | −$11.07 | −$11.60 | -4.82% | $990,000.00 | $2.1M |
| Q2 2022 | Aug 10, 2022 | −$13.15 | −$12.20 | 7.22% | $500,000.00 | $1.4M |
| Q1 2022 | May 12, 2022 | −$14.05 | −$12.80 | 8.90% | $500,000.00 | $813,000.00 |
| Q4 2021 | Mar 30, 2022 | −$16.16 | −$14.60 | 9.65% | $375,000.00 | $508,000.00 |
| Q3 2021 | Nov 9, 2021 | −$15.00 | −$12.60 | 16.00% | $375,000.00 | $752,000.00 |
| Q2 2021 | Aug 12, 2021 | −$11.70 | −$12.80 | -9.40% | $3.3M | — |
| Q1 2021 | May 13, 2021 | −$13.65 | −$21.80 | -59.71% | — | — |
| Q4 2020 | Mar 31, 2021 | −$12.87 | −$291.40 | -2164.76% | $33,333.00 | — |

## Frequently Asked Questions

### When did Bolt Biotherapeutics (BOLT) last report earnings?

Bolt Biotherapeutics last reported on Aug 14, 2025, covering fiscal Q2 2025.

### Did BOLT beat earnings estimates?

Yes. Bolt Biotherapeutics reported EPS of −$4.46 for Q2 2025 against a −$6.30 estimate — a 29.21% beat.

### How much revenue did BOLT report last quarter?

Bolt Biotherapeutics reported $1.8M in revenue for Q2 2025, against a consensus estimate of $819,750.00.

---

Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).